Skip Navigation

Cardiovascular Research 2006 70(1):97-106; doi:10.1016/j.cardiores.2006.02.002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Martin, S. R.
Right arrow Articles by Casadei, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, S. R.
Right arrow Articles by Casadei, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Are myocardial eNOS and nNOS involved in the β-adrenergic and muscarinic regulation of inotropy? A systematic investigation

Sarah R. Martin1, Krzysztof Emanuel1, Claire E. Sears, Yin-Hua Zhang and Barbara Casadei*

Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK

* Corresponding author. Tel.: +44 1865 220132; fax: +44 1865 768844. Email address: barbara.casadei{at}cardiov.ox.ac.uk

Objective The role of constitutive nitric oxide (NO) production in the regulation of β-adrenergic and muscarinic responses remains controversial. Conflicting data in left ventricular (LV) myocytes from eNOS knockout mice (eNOS– / –) have been ascribed to inconsistent experimental conditions (i.e., differences in the choice of controls, age of the mice, myocytes' stimulation frequency, and in the level of β-adrenergic stimulation); however, the recent identification of a neuronal-like NO synthase (nNOS) in the LV myocardium has raised the possibility that this isoform may be involved in the modulation of β-adrenergic and muscarinic responses.

Methods To address these issues we recorded sarcomere shortening at 35 °C under basal conditions, in the presence of isoproterenol (ISO, 10–100 nmol/L) and of ISO plus carbamylcholine (CCh, 1 µmol/L) in LV myocytes isolated from eNOS– / – and nNOS– / – mice, their wild type littermates (eNOS+/+ and nNOS+/+) or C57BL/6J mice. eNOS– / – and control myocytes were studied at 1 and 3 Hz, in the presence of 10 and 100 nmol/L ISO, and responses were compared between young (3 months) and old (leg12 months) mice.

Results Contraction did not differ between young eNOS / – and eNOS+/+ mice at all stages of the experimental protocol, either at 1 or 3 Hz or in response to 10 or 100 nmol/L ISO. However, myocytes from old eNOS– / – mice showed a reduced inotropic response to ISO compared with age-matched eNOS+/+ mice (P=0.02). Similarly, there was a significant difference in the ISO response between eNOS+/+ and C57BL/6J myocytes (P<0.01), suggesting that experimental variables such as age and the choice of control animals may have contributed to the inconsistency in the results reported in the literature. In contrast, nNOS / – myocytes showed greater contraction and slower relaxation at all stages of the experimental protocol (P=0.0003 and P=0.01 vs. nNOS+/+ myocytes).

Conclusions Constitutive eNOS expression in murine LV myocytes is not essential for the muscarinic-mediated inhibition of β-adrenergic signalling and does not appear to play a significant role in the regulation of basal and β-adrenergic myocardial contraction. Our data suggest that nNOS is the myocardial constitutive isoform responsible for the NO-mediated autocrine regulation of myocardial inotropy and relaxation.

KEYWORDS Nitric oxide; β-Adrenergic; Cholinergic; Inotropy; Autocrine; nNOS; eNOS; Age; Wild type controls


1 These authors have contributed equally to this work.

Time for primary review 32 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-B. Shen, R. Shutt, M. Agosto, A. Pappano, and B. T. Liang
Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1089 - H1095.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Wang, M. J. Kohr, C. J. Traynham, D. G. Wheeler, P. M. L. Janssen, and M. T. Ziolo
Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1566 - C1575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wang, M. J. Kohr, D. G. Wheeler, and M. T. Ziolo
Endothelial nitric oxide synthase decreases {beta}-adrenergic responsiveness via inhibition of the L-type Ca2+ current
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1473 - H1480.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Fukuda, J. O-Uchi, and S. Kurihara
Neuronal NO Synthase-Derived NO: A Novel Relaxing Factor in Myocardium?
Circ. Res., February 1, 2008; 102(2): 148 - 150.
[Full Text] [PDF]


Home page
Circ. Res.Home page
Y. H. Zhang, M. H. Zhang, C. E. Sears, K. Emanuel, C. Redwood, A. El-Armouche, E. G. Kranias, and B. Casadei
Reduced Phospholamban Phosphorylation Is Associated With Impaired Relaxation in Left Ventricular Myocytes From Neuronal NO Synthase-Deficient Mice
Circ. Res., February 1, 2008; 102(2): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Lim, L. Venetucci, D. A. Eisner, and B. Casadei
Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling
Cardiovasc Res, January 15, 2008; 77(2): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. W.T. Liu and P. L. Huang
Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice
Cardiovasc Res, January 1, 2008; 77(1): 19 - 29.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. H. Vandsburger, B. A. French, P. A. Helm, R. J. Roy, C. M. Kramer, A. A. Young, and F. H. Epstein
Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated {beta}-adrenergic functional response in neuronal nitric oxide synthase knockout mice
Eur. Heart J., November 2, 2007; 28(22): 2792 - 2798.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Seddon, A. M. Shah, and B. Casadei
Cardiomyocytes as effectors of nitric oxide signalling
Cardiovasc Res, July 15, 2007; 75(2): 315 - 326.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
B. Casadei
The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function
Exp Physiol, November 1, 2006; 91(6): 943 - 955.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.